Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

PDS Biotechnology Corporation PDSB

Set alert

Price alert · PDSB

All alert types
1.37 USD -0.07 -4.86%

At close

1.39 +0.02 +1.44%

Pre-market · Nov 3, 5:08 AM ET

Bid
1.37 × 1
Ask
1.38 × 1
1.32 Day range 1.47
0.195 52-week range 1.79
YTD
+77.92%
1 year
+46.52%
Open
1.49
Prev close
1.44
Mkt cap
143.86M
Vol
4.12M
Avg vol
25.57M
EPS
-0.64
P/E
0.00
Div yield
0.00%
More statistics
Low
1.32
High
1.47
Forward P/E
-1.18
Beta
1.93
Short ratio
10.47
Inst. own
12.36%
Dividend
0.00
Ex-div date
50-d avg
2.60
200-d avg
3.22
1y target
11.50

5D chart

Chart tools
Interval
1m5m15m30m

Signals (73)
NameTimeAgo
MACD: Buy SignalNov 2, 2:05 PM15 hours ago
MACD: Sell SignalNov 2, 12:30 PM16 hours ago
MACD: Buy SignalNov 2, 11:30 AM17 hours ago
SMA: BullishNov 2, 11:25 AM17 hours ago
SMA: BullishNov 2, 11:25 AM17 hours ago
MACD: Sell SignalNov 2, 10:45 AM18 hours ago
SMA: BearishNov 2, 10:40 AM18 hours ago
MACD: Buy SignalNov 2, 10:25 AM18 hours ago
SMA: BullishNov 2, 10:15 AM18 hours ago
SMA: BearishNov 2, 9:35 AM19 hours ago
MACD: Sell SignalNov 2, 9:35 AM19 hours ago
RSI: OverboughtOct 30, 3:35 PM3 days ago
SMA: BullishOct 30, 3:20 PM3 days ago
SMA: BullishOct 30, 2:15 PM3 days ago
MACD: Buy SignalOct 30, 1:35 PM3 days ago
MACD: Sell SignalOct 30, 1:30 PM3 days ago
SMA: BearishOct 30, 12:45 PM3 days ago
SMA: BearishOct 30, 11:20 AM3 days ago
MACD: Buy SignalOct 30, 10:55 AM3 days ago
RSI: OversoldOct 30, 10:05 AM3 days ago

Newest 20 of 73.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 11.50 +739.4% upside
Target (low)
4.50
Target (mean)
11.50
Target (high)
21.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 6
  • 2 months ago 6
  • 3 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PDSB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.29667-0.34 – -0.25-0.35+15.2%00.0%6
Next quarter-0.33333-0.37 – -0.29-0.30-11.1%00.0%3
Current year-1.13-1.19 – -1.10-1.39+18.7%00.0%6
Next year-1.42-1.95 – -1.15-1.13-25.8%00.0%6

Upgrades and downgrades

The latest rating changes

PDSB analyst upgrades and downgrades
DateFirmActionFromTo
Dec 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 25, 2024B. Riley SecuritiesMaintainedBuyBuy
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 2, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 20, 2024Alliance Global PartnersMaintainedBuyBuy
Aug 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 12, 2024B. Riley SecuritiesMaintainedBuyBuy
May 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 9, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 9, 2024Cantor FitzgeraldReiterated—Overweight
Mar 28, 2024B. Riley SecuritiesReiteratedBuyBuy
Mar 27, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 15, 2023OppenheimerMaintainedOutperformOutperform
Oct 11, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 27, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 20, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 14, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 6, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 26, 2023OppenheimerReiteratedOutperformOutperform
May 26, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2023OppenheimerReiterated—Outperform
Apr 24, 2023HC Wainwright & Co.Reiterated—Buy
Mar 30, 2023HC Wainwright & Co.Reiterated—Buy
Mar 29, 2023B. Riley SecuritiesReiterated—Buy
Mar 28, 2023HC Wainwright & Co.Reiterated—Buy
Feb 28, 2023HC Wainwright & Co.Maintained—Buy
Jan 3, 2023HC Wainwright & Co.Maintained—Buy